Gara Jalqabaatti › Diffuse Large B-Cell Lymphoma › Utah › Salt Lake City
Qorannoo klinikaalii Diffuse Large B-Cell Lymphoma Salt Lake City, UT keessatti
Qorannoo 12 Diffuse Large B-Cell Lymphoma f Salt Lake City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Namoota walitti qabaa jiraSadarkaa 2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
- Intermountain Health LDS Hospital, Salt Lake City
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Namoota walitti qabaa jiraSadarkaa 1
- Intermountain Healthcare, Salt Lake City
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Namoota walitti qabaa jiraSadarkaa 1/2
- Intermountain - Primary Children's Hospital ( Site 1014), Salt Lake City
Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- Huntsman Cancer Institute, Salt Lake City
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Namoota walitti qabaa jiraSadarkaa 3
- Intermountain Healthcare, Salt Lake City
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL
Namoota walitti qabaa jiraSadarkaa 1
- Huntsman Cancer Institute at University of Utah, Salt Lake City
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Namoota walitti qabaa jiraSadarkaa 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Namoota walitti qabaa jiraSadarkaa 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
Namoota walitti qabaa jiraSadarkaa 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Qorannoo Diffuse Large B-Cell Lymphoma magaalota biroo keessatti
- New York City, NYQorannoo 21
- Baldwin Park, CAQorannoo 19
- Chicago, ILQorannoo 18
- Houston, TXQorannoo 17
- Los Angeles, CAQorannoo 17
- Milwaukee, WIQorannoo 16
- Boston, MAQorannoo 16
- Nashville, TNQorannoo 15
- Philadelphia, PAQorannoo 15
- Portland, ORQorannoo 15
- Durham, NCQorannoo 14
- Dallas, TXQorannoo 13
Qorannoo biroo Salt Lake City keessatti
- Kansara Qara'a Non-Small CellQorannoo 31
- Saree (Gosoota Hunda)Qorannoo 27
- Saree OljooQorannoo 27
- Kansarii ColorectalQorannoo 22
- Dhibee QaraQorannoo 21
- MelanomaQorannoo 21
- Myeloma Baay’eeQorannoo 21
- Kansara MetastatikiiQorannoo 20
- Kansarii OvariiQorannoo 19
- ObesityQorannoo 18
- Leukemia Myeloidii HamaaQorannoo 17
- Cufama OnneeQorannoo 17
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.